Learning Objectives

After participating in this activity, health care professionals should be able to

  • Describe some of the advances of immunotherapies in the treatment of breast cancer
  • List phenotypic and functional assays available for quantitating immune responses to cancer vaccines
  • Explain the use of dendritic cells in the generation of cancer vaccines
  • Recognize the role of MUC-1 as a potential target for immunotherapy in cancer
  • Identify the potential applications of genetic profiling in breast cancer diagnosis and treatment

When choosing among continuing education activities, clinicians should select those that are appropriate for their educational needs. Participants in educational activities have the implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional effectiveness. Clinicians should reflect on this activity and its applicability to their own patient population, and then identify and implement appropriate practice changes.